Fingerprint
Dive into the research topics of 'A plain language summary of the CAPItello-291 study: Capivasertib in hormone receptor-positive advanced breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A plain language summary of the CAPItello-291 study: Capivasertib in hormone receptor-positive advanced breast cancer
Nicholas C Turner, Mafalda Oliveira, Sacha J Howell, Florence Dalenc, Javier Cortés, Henry L Gomez, Xichun Hu, Komal Jhaveri, Petr Krivorotko, Sibylle Loibl, Serafin Morales Murillo, Yeon Hee Park, Joo-Hyuk Sohn, Masakazu Toi, Eriko Tokunaga, Samih Yousef, Lyudmila Zhukova, Elza de Bruin, Lynda Grinsted, Gaia Schiavon
- Vall D'Hebron Institute of Oncology
- IUCT Oncopole
- International Breast Cancer Center (IBCC)
- Instituto Nacional de Enfermedades Neoplásicas (INEN)
- Fudan University Shanghai Cancer Center
- Memorial Sloan Kettering Cancer Center
- N.N. Petrov National Medical Research Institute of Oncology
- GBG Forschungs GmbH (German Breast Group)
- Institut de Recerca Biomèdica Lleida
- Sungkyunkwan University
- Yonsei University College of Medicine
- Kyoto University Hospital
- National Hospital Organization Kyushu Cancer Center
- Emek Medical Center
- The Loginov Moscow Clinical Scientific Center
- University of California
Research output: Contribution to journal › Article › peer-review